Serial immune function testing to predict clinical disease relapse in patients with solid tumors.
作者信息
Braun D P, Harris J E
出版信息
Cancer Immunol Immunother. 1983;15(3):165-71. doi: 10.1007/BF00199159.
Abstract
摘要
相似文献
1
Serial immune function testing to predict clinical disease relapse in patients with solid tumors.
Cancer Immunol Immunother. 1983;15(3):165-71. doi: 10.1007/BF00199159.
2
Clinical assessment of T and B lymphocyte functions.
R I Med J (1976). 1976 Feb;59(2):51-6, 71.
3
In vitro tests of cellular immunity in man.
Invest Cell Pathol. 1978 Jul-Sep;1(3):227-48.
4
Report of a workshop on the immune response to solid tumours in man.
Int J Cancer. 1975 Dec 15;16(6):887-96. doi: 10.1002/ijc.2910160602.
5
Influence of poly (A)-poly (U) on immune response in cancer patients.
Ann N Y Acad Sci. 1976;277(00):288-98. doi: 10.1111/j.1749-6632.1976.tb41706.x.
6
[Immunological status of patients with solid neoplasms].
Minerva Chir. 1980 May 31;35(10):717-22.
7
[Current tests for the "in vitro" immunologic exploration in man].
Arch Inst Pasteur Tunis. 1979 Mar-Jun;56(1-2):39-52.
8
[T and B-lymphocytes and immunoglobulins in solid tumors].
Rev Clin Esp. 1974 Mar 31;132(6):501-4.
9
Basics in practical applications and standardization of techniques of cellular immunology.
Lab Res Methods Biol Med. 1983;8:71-8.
10
Lymphocyte-mediated immune responses in neoplasia.
Am J Clin Pathol. 1974 Aug;62(2):184-211. doi: 10.1093/ajcp/62.2.184.
引用本文的文献
1
Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.
Br J Cancer. 2001 Jun 15;84(12):1624-9. doi: 10.1054/bjoc.2001.1847.
2
Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.
Br J Cancer. 1994 Dec;70(6):1247-51. doi: 10.1038/bjc.1994.481.
3
Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.
Cancer Immunol Immunother. 1986;22(2):87-94. doi: 10.1007/BF00199120.
4
Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.
Cancer Immunol Immunother. 1989;28(4):287-95. doi: 10.1007/BF00205239.
本文引用的文献
1
The value of lymphocyte transformation in carcinoma of the colon and rectum.
Surg Gynecol Obstet. 1980 May;150(5):687-93.
2
Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.
J Neurosurg. 1981 Mar;54(3):331-7. doi: 10.3171/jns.1981.54.3.0331.
3
Immune responses of human lymphocytes in vitro.
Prog Clin Immunol. 1980;4:23-62.
4
The measurement of leukocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody reagents.
Med Pediatr Oncol. 1982;10(2):185-94. doi: 10.1002/mpo.2950100214.
5
Lack of correlation of T and B lymphocytes with stage of colorectal carcinoma.
Dis Colon Rectum. 1980 Mar;23(2):65-7. doi: 10.1007/BF02587593.
6
Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer.
Cancer Immunol Immunother. 1982;13(3):164-73. doi: 10.1007/BF00205382.
7
Serial immune testing in surgically resected lung cancer patients.
Cancer Immunol Immunother. 1983;15(2):114-20. doi: 10.1007/BF00199701.
8
Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
Clin Immunol Immunopathol. 1981 Aug;20(2):193-214. doi: 10.1016/0090-1229(81)90178-1.
9
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
J Clin Invest. 1980 Jul;66(1):149-58. doi: 10.1172/JCI109828.
10
Persistent lymphocytopenia as a diagnostic feature of bronchogenic carcinoma.
Chest. 1980 Oct;78(4):583-6. doi: 10.1378/chest.78.4.583.
Zotero 插件